Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023

We report a surge of patients, especially children and adolescents, with respiratory disease caused by Mycoplasma pneumoniae in Denmark since October 2023. While the surge has reached an epidemic level, no impact on hospital capacity has been observed; only 14% (446/3,195) of cases, primarily adults, required hospitalisation. Macrolide resistance was detected in less than 2% of samples tested. Timely monitoring of hospitalisations linked to M. pneumoniae infections has been established to inform the healthcare system, decisionmakers and the public.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 29(2024), 2 vom: 12. Jan.

Sprache:

Englisch

Beteiligte Personen:

Nordholm, Anne Christine [VerfasserIn]
Søborg, Bolette [VerfasserIn]
Jokelainen, Pikka [VerfasserIn]
Lauenborg Møller, Karina [VerfasserIn]
Flink Sørensen, Lotte [VerfasserIn]
Grove Krause, Tyra [VerfasserIn]
Anker Uldum, Søren [VerfasserIn]
Emborg, Hanne-Dorthe [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Epidemiology
Journal Article
M. pneumoniae, surveillance
Macrolides
Public health
Respiratory infection
Resurgence

Anmerkungen:

Date Completed 15.01.2024

Date Revised 15.01.2024

published: Print

Citation Status MEDLINE

doi:

10.2807/1560-7917.ES.2024.29.2.2300707

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367046350